Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD Effects of Vaping THC vs. Smoked Cannabis
NCT06055231Phase 1Not yet recruiting
- Sponsor
- Roswell Park Comprehensive Cancer Center
- Start
- Dec 2026
- Primary completion
- Mar 2027
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of dronabinol (2 arms), sponsored by Roswell Park Comprehensive Cancer Center. Primary endpoints: Peak Plasma Concentration at 360 minutes, Area under the plasma concentration time curve from 0-360 minutes and 1 more. Planned start Dec 2026; status: not yet recruiting.
02
Drugs
dronabinol
Beyond the preview
Go deeper on NCT06055231.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06055231.